Google Ads for body contouring and aesthetic weight-loss clinics companies in the UK

A size-16 dress goes back on the hanger because the zip won’t close. That’s not a quiet scroll through Instagram at ten o’clock at night - that’s the exact second a thumb opens Google and types “weight loss clinic near me,” or the name of the injection a friend mentioned at a hen do. The search happens in a moment of frustration, not research. Whoever shows up well in that moment, with the right words and the right page behind the ad, gets the consult booked.

Most clinics don’t lose that enquiry because nobody searched. They lose it because the ad that showed up either said something it legally shouldn’t have, or said nothing useful at all out of fear of saying the wrong thing. Both versions cost you the same thing: a wasted click, a disapproved ad group, or a consult that goes to the clinic three postcodes over that worded things more carefully. And in this category, the margin for error is thinner than almost any other local service business HeyLead works with, because the Advertising Standards Authority and the Medicines and Healthcare products Regulatory Agency are both watching what you write before a customer ever sees it.

Here’s the insight that changes how you build the account: your Google Ads strategy for body contouring and medical weight-loss has to work around one hard legal line, not blur it. Prescription-only medicines, which includes semaglutide and tirzepatide brands, cannot be advertised to the public under the Human Medicines Regulations 2012. Body contouring devices and the consultation itself can be. Get that split right and you capture the demand you’re entitled to. Get it wrong and Google’s own compliance team, not just the ASA, pulls your ads before a prospective patient ever lands on your page.

The ASA line between a body contouring ad and a prescription medicine ad

There are actually two separate gatekeepers here, and clinics tend to only plan for one of them. The first is the UK’s advertising self-regulation system: the Committee of Advertising Practice writes the rules, the ASA enforces them, and the rule that matters most for this niche is straightforward. Prescription-only medicines can’t be advertised to the public, full stop. That covers the branded injectable weight-loss drugs your patients are almost certainly asking about by name, whatever the brand. You can discuss weight management as a service. You can’t advertise the medicine.

The second gatekeeper is Google itself, and this one moves faster than any ASA ruling. Google Ads runs its own healthcare and medicines policy on top of UK advertising law, and it enforces restrictions on prescription pharmaceutical advertising independently of what CAP says. That means an ad can clear every compliance check you’ve run internally and still get disapproved within hours, because Google’s automated review flagged a drug name, a dosage reference, or even a generic phrase like “get your prescription today.” We’ve seen clinics lose a week of a launch campaign to exactly this, not because the offer was wrong, but because one headline variant in a responsive search ad happened to mention the drug class.

The practical upshot: you’re not writing one set of ad copy rules, you’re writing two, and the stricter one usually wins. Build your account on the assumption that any reference to a specific prescription medicine, by brand or close paraphrase, gets the ad pulled. What survives that filter is still a genuinely strong offer: the clinical assessment, the eligibility check, the programme, the device-based treatment, the aftercare. None of that needs the drug name to convert a patient who’s already decided they want help.

What you can still say, and the account structure that captures it anyway

Once you accept the restriction instead of fighting it, the keyword and campaign structure practically writes itself. Body contouring treatments like fat freezing, EMSculpt-style muscle stimulation, and non-surgical skin tightening aren’t prescription medicines, so they’re fair game for direct, specific ad copy, branded extensions, and competitor-level targeting. The weight-loss injection side of the business needs a different lane: campaigns built around the consultation, the eligibility criteria, and the clinical pathway, never the drug itself.

Search terms reports in this niche get messy fast. Patients search the drug brand name constantly, and if you’re not actively excluding those exact queries from triggering your ads, you’ll either waste spend on clicks that can’t legally convert into the ad message they expect, or you’ll trip Google’s own filters without meaning to. Negative keyword lists need to work harder here than in almost any other local vertical, because the words patients use and the words you’re allowed to use in reply are two different vocabularies.

Pricing creates its own trap. Cosmetic treatments in the UK are standard-rated for VAT, not exempt, because the exemption only applies to treatment of a diagnosed medical condition, not elective aesthetic work. Any “from £X” price shown in an ad or on the landing page needs to be VAT-inclusive, or you’re one misleading-pricing complaint away from an ASA ruling that costs you more in reputation than the campaign ever earned in consults. Clinics that advertise a net price and add VAT at checkout get reported, and the ASA does act on it.

If you want a second set of eyes on where the structure is leaking, HeyLead’s Google Ads management for UK clinics starts with exactly this kind of split audit before touching a single bid.

The disapprovals and wasted spend pattern clinics fall into

Chasing impressions is the easiest trap in this category, because the search volume around weight-loss injections is genuinely huge right now, and it’s tempting to read a busy account as a healthy one. Industry-wide, Google Ads delivers an average ROAS somewhere near 4.2x across all sectors in current benchmark data, but aesthetic and medical-adjacent keywords sit in a different cost bracket entirely, because you’re competing against pharma-adjacent advertisers and well-funded national chains. High click volume on broad weight-loss terms without a tight enough negative list just buys you expensive clicks from people hunting for an online prescription, not a consultation.

Testimonials are the second recurring mistake. The CAP code is clear that testimonials used in ads need to be genuine and can’t imply a guaranteed or typical result just because one patient had an exceptional outcome. Clinics that lift a glowing review straight onto a landing page without checking whether it implies a universal result, or whether it was solicited in a way that meets consent rules, are building the exact kind of claim the ASA investigates. It’s an easy fix: show real outcomes, but frame them as individual experiences, not promises.

The quieter cost is the handoff after the click. Plenty of clinics run a genuinely compliant, well-targeted campaign and still send that traffic to a generic homepage instead of a page built around the specific treatment the ad promised. A patient who clicked an ad about fat freezing and lands on a page listing twelve unrelated services, with no clear next step, bounces. That’s not a targeting problem, it’s a conversion problem, and it’s one of the most common reasons spend looks fine in the Google Ads dashboard while consults stay flat. Session recordings and scroll-depth data through HeyLead Insights usually show exactly where that patient gave up, whether it’s a form that asks for too much before the first contact, or a price that appears before the eligibility conversation has even started.

Attribution rounds out the list. A lead that fills in a form isn’t the same as a patient who showed up to the consult, and smart bidding optimises toward whatever signal you feed it. Clinics running on form-fill data alone end up with an algorithm chasing cheap, low-quality leads, because that’s the only outcome it can see. Feeding confirmed, attended consults back into Google Ads as offline conversions, pulled from the booking calendar rather than the CRM’s first touch, gives the bidding system something worth optimising for.

What clinic managers say about the compliance and consult gap

“We kept getting disapproved for mentioning the injection by name, even in a question format, before we understood Google was reading it the same way as a direct advert for the drug.”

Owner, two-site medical aesthetics clinic

“The enquiries that come in at night, after someone’s had a rough day with their clothes, are the ones we used to lose completely. Getting WhatsApp into the funnel properly changed that more than any bid adjustment did.”

Practice manager, non-surgical body contouring clinic

FAQ: questions clinics ask about running compliant Google Ads

Can we mention Mounjaro, Wegovy, or Ozempic by name in a Google Ads campaign? No. These are prescription-only medicines, and the Human Medicines Regulations 2012 prohibit advertising them to the public. Google’s own ad policy enforces this independently of the ASA and will disapprove ads that reference the brand or strongly imply it.

Does the same restriction apply to Meta and Instagram ads? Yes, in principle. The underlying law doesn’t change by platform, and Meta applies its own health and medical products restrictions as well. Treat every paid channel as subject to the same line, not just Google.

What can we actually say about weight-loss injections in our marketing? You can advertise the clinical consultation, the assessment process, eligibility criteria, and the broader weight management programme. What you can’t do is advertise the specific medicine, its availability, or imply you’re selling the prescription itself through the ad.

Do we need to show VAT in our advertised prices? Cosmetic and aesthetic treatments are standard-rated, so any price shown in an ad, on a landing page, or in a price list needs to already include VAT at 20%. Advertising a net figure and adding VAT later is a common cause of ASA complaints.

How fast does Google flag non-compliant ad copy? Often within hours, sometimes before the ad has served meaningfully at all. Automated review catches obvious drug references quickly, though borderline phrasing can slip through initially and get pulled days later once it’s reviewed manually.

Putting it to work

This week, pull your search terms report for the last 30 days and scan it specifically for prescription drug brand names triggering your ads, whether they’re excluded as negatives or not. It takes about twenty minutes and tells you immediately whether you’re paying for clicks that can’t legally convert the way your ad promises, and whether Google’s review process is quietly throttling your best-performing ad groups without you noticing.

Building a Google Ads account for this category means working inside two overlapping rule sets while still capturing a search demand that’s moving fast, and getting the keyword split, the landing page handoff, and the conversion tracking all pulling in the same direction. HeyLead runs that structure end to end for UK body contouring and medical weight-loss clinics, from the compliant campaign build through attribution that tells you which consults actually got booked, not just which forms got filled. Chat with us on WhatsApp.